share_log

康哲藥業：截至二零二三年十二月三十一日止年度之末期股息

CMS: FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023

香港交易所 ·  Mar 27 10:47
Summary by Moomoo AI
康哲藥業控股有限公司（股份代號：00867），於2024年3月27日宣布將派發截至2023年12月31日止年度的末期普通股息。每股股息為0.0783人民幣，將按1人民幣兌1.1026港幣的匯率，折合每股0.086港幣。股東批准日期定於2024年5月9日。股息除淨日為2024年5月13日，而股份過戶登記將於2024年5月16日暫停一天。記錄日期為同年5月16日，股息派發日則定於2024年5月23日。本次股息派發的決定由公司董事會作出，包括執行董事林剛先生、陳洪兵先生及陳燕玲女士，以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
康哲藥業控股有限公司（股份代號：00867），於2024年3月27日宣布將派發截至2023年12月31日止年度的末期普通股息。每股股息為0.0783人民幣，將按1人民幣兌1.1026港幣的匯率，折合每股0.086港幣。股東批准日期定於2024年5月9日。股息除淨日為2024年5月13日，而股份過戶登記將於2024年5月16日暫停一天。記錄日期為同年5月16日，股息派發日則定於2024年5月23日。本次股息派發的決定由公司董事會作出，包括執行董事林剛先生、陳洪兵先生及陳燕玲女士，以及獨立非執行董事梁創順先生、羅瑩女士及馮征先生。
CONGE PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 00867) ANNOUNCED ON 27 MARCH 2024 THAT IT WILL DISTRIBUTE THE FINAL ORDINARY DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023. The dividend per share is RMB 0.0783, at an exchange rate of RMB1.1026 at RMB 1.1026, compounded by HK$0.086 per share. Shareholders' approval date is set for May 9, 2024. The net dividend distribution date is May 13, 2024, and share transfer registration will be suspended for one day on May 16, 2024. The record date is 16 May of the same year and the dividend date is set for 23 May 2024. THE DECISION TO DISTRIBUTE THIS DIVIDEND IS MADE BY THE COMPANY'S BOARD OF DIRECTORS, INCLUDING EXECUTIVE DIRECTORS MR. LIN KANG, MR. CHAN HUNG BING AND MS. CHAN YANLING, AS WELL AS INDEPENDENT NON-EXECUTIVE DIRECTORS MR. LEUNG CHUNG SHUN, MS. LAO YING AND MR. FUNG ZHENG.
CONGE PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 00867) ANNOUNCED ON 27 MARCH 2024 THAT IT WILL DISTRIBUTE THE FINAL ORDINARY DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023. The dividend per share is RMB 0.0783, at an exchange rate of RMB1.1026 at RMB 1.1026, compounded by HK$0.086 per share. Shareholders' approval date is set for May 9, 2024. The net dividend distribution date is May 13, 2024, and share transfer registration will be suspended for one day on May 16, 2024. The record date is 16 May of the same year and the dividend date is set for 23 May 2024. THE DECISION TO DISTRIBUTE THIS DIVIDEND IS MADE BY THE COMPANY'S BOARD OF DIRECTORS, INCLUDING EXECUTIVE DIRECTORS MR. LIN KANG, MR. CHAN HUNG BING AND MS. CHAN YANLING, AS WELL AS INDEPENDENT NON-EXECUTIVE DIRECTORS MR. LEUNG CHUNG SHUN, MS. LAO YING AND MR. FUNG ZHENG.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more